Approval · Notice of Compliance 8076 · 2006
GLUCOPHAGE: Notice of Compliance 8076
Issued June 22, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8076
- Date
- June 22, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph
- Therapeutic class
- Oral antihyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUCOPHAGE | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB